PTH[1-34], but not alendronate, increases bone quality in trabecular bone in a rat model of osteoporosis.

被引:0
|
作者
Jorgensen, N. R.
Thorkildsen, C.
Jensen, J. B.
Petersen, J. S.
Schwarz, P.
机构
[1] Univ Copenhagen, Hvidovre Hosp, Dept Endocrinol, DK-2650 Hvidovre, Denmark
[2] Univ Copenhagen, Hvidovre Hosp, Dept Clin Biochem, DK-2650 Hvidovre, Denmark
[3] Zealand Pharma AS, Glostrup, Denmark
[4] Univ Copenhagen, Glostrup Hosp, Res Ctr Ageing & Osteoporosis, Dept Geriatr, Glostrup, Denmark
关键词
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:S297 / S297
页数:1
相关论文
共 50 条
  • [1] PTH increases bone mineral density and resistance to mechanical load in a rat model of osteoporosis.
    Henriksen, Z
    Thorkildsen, C
    Jensen, JEB
    Jorgensen, NR
    JOURNAL OF BONE AND MINERAL RESEARCH, 2004, 19 : S460 - S461
  • [2] PTH (1-34) increases bone mass in monkeys.
    Brommage, R
    Hotchkiss, CE
    Lees, CJ
    Hock, JM
    Jerome, CP
    JOURNAL OF BONE AND MINERAL RESEARCH, 1997, 12 : T544 - T544
  • [3] Histomorphometry and microstructure of iliac trabecular bone in osteoporosis on intermittent subcutaneous administration of human PTH (1-34)
    Nakatsuka, K
    Naka, H
    Kawakami, H
    Kitatani, K
    Miki, T
    Nishizawa, Y
    Morii, H
    BONE, 2001, 28 (05) : S240 - S241
  • [4] Interaction among Calcium Diet Content, PTH (1-34) Treatment and Balance of Bone Homeostasis in Rat Model: The Trabecular Bone as Keystone
    Ferretti, Marzia
    Cavani, Francesco
    Roli, Laura
    Checchi, Marta
    Magaro, Maria Sara
    Bertacchini, Jessika
    Palumbo, Carla
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2019, 20 (03):
  • [5] Alendronate increases bone mineral density in male idiopathic osteoporosis.
    Weber, TJ
    Drezner, MK
    JOURNAL OF BONE AND MINERAL RESEARCH, 1999, 14 : S278 - S278
  • [6] PTH [1-34] enhances bone response around titanium implants in a rabbit model of osteoporosis
    Isabel Almagro, M.
    Roman-Blas, Jorge A.
    Bellido, Miriam
    Castaneda, Santos
    Cortez, Raul
    Herrero-Beaumont, Gabriel
    CLINICAL ORAL IMPLANTS RESEARCH, 2013, 24 (09) : 1027 - 1034
  • [7] Mechanisms of vasodilation to PTH 1-84, PTH 1-34, and PTHrP 1-34 in rat bone resistance arteries
    Benson, T.
    Menezes, T.
    Campbell, J.
    Bice, A.
    Hood, B.
    Prisby, R.
    OSTEOPOROSIS INTERNATIONAL, 2016, 27 (05) : 1817 - 1826
  • [8] Bone-selective analogs of human PTH(1-34) increase bone formation in an ovariectomized rat model
    Lane, NE
    Kimmel, DB
    Nilsson, MHL
    Cohen, FE
    Newton, S
    Nissenson, RA
    Strewler, GJ
    JOURNAL OF BONE AND MINERAL RESEARCH, 1996, 11 (05) : 614 - 625
  • [9] In primates, treatment with PTH (1-34), LY333334, increases bone strength at trabecular bone sites without compromising the strength of cortical bone.
    Turner, CH
    Wang, T
    Hirano, T
    Burr, DB
    Hock, JM
    Hotchkiss, CE
    Brommage, R
    Jerome, CP
    JOURNAL OF BONE AND MINERAL RESEARCH, 1999, 14 : S414 - S414
  • [10] Recombinant human parathyroid hormone (1-34) increases bone mineral density in men with both idiopathic and hypogonadal osteoporosis.
    Orwoll, ES
    Scheele, WH
    Clancy, AD
    Adami, S
    Syversen, U
    Kaufman, JM
    Diez-Perez, A
    ARTHRITIS AND RHEUMATISM, 2001, 44 (09): : S379 - S379